Anna Mais
Impact in
-
- Osteoarthritis Treatment and Mechanisms
-
- Peptidase Inhibition and Analysis
Papers in
-
- Histone Deacetylase Inhibitors Research 6
- Protein Degradation and Inhibitors 2
- Oncology 7
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Gereon Lauer (2 shared papers)Hannsjörg W. Seyberth (1 shared paper)Mark Dominik Alscher (1 shared paper)Stefanie S. Brenner (1 shared paper)Ulrich Klotz (1 shared paper)Bernhard Hauns (9 shared papers)Horst Schweer (1 shared paper)Péter Fritz (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Blood (2 papers)Clinical Cancer Research (1 paper)Journal of Cellular Biochemistry (1 paper)Journal of Crohn s and Colitis (1 paper)
- Partner nations
- GermanySwitzerlandPoland
In The Last Decade
Anna Mais
15 papers receiving 207 citations
Peers
Comparison fields: 5 of 43
- Rheumatology 37
- Oncology 52
- Molecular Biology 120
- Hepatology 11
- Genetics 12
Countries citing papers authored by Anna Mais
This map shows the geographic impact of Anna Mais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mais more than expected).
Fields of papers citing papers by Anna Mais
This network shows the impact of papers produced by Anna Mais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mais. The network helps show where Anna Mais may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Mais, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 60 | |
| 2 | 2013 | 42 | |
| 3 | 2018 | 20 | |
| 4 | 2020 | 12 | |
| 5 | 2006 | 12 | |
| 6 | 2018 | 11 | |
| 7 | 2014 | 10 | |
| 8 | 2012 | 8 | |
| 9 | 2014 | 8 | |
| 10 | 2013 | 7 | |
| 11 | 2011 | 7 | |
| 12 | 2012 | 6 | |
| 13 | 2010 | 6 | |
| 14 | 2013 | 1 | |
| 15 | 2020 | 1 |
About Anna Mais
Anna Mais is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hepatology and Pathology and Forensic Medicine, having authored 15 papers that have together received 211 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (6 papers), Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Protein Degradation and Inhibitors (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Rheumatology (37 citations), Oncology (52 citations), Molecular Biology (120 citations), Hepatology (11 citations) and Genetics (12 citations). Anna Mais has collaborated with scholars based in Germany, Switzerland and Poland. Frequent co-authors include Gereon Lauer, Hannsjörg W. Seyberth, Mark Dominik Alscher, Stefanie S. Brenner, Ulrich Klotz, Bernhard Hauns, Horst Schweer, Péter Fritz, Ann Parker and L. Rhoda Molife. Their work appears in journals such as Journal of Clinical Oncology, Blood, Clinical Cancer Research, Journal of Cellular Biochemistry and Journal of Crohn s and Colitis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.